Works matching IS 13570560 AND DT 2015 AND VI 32 AND IP 3

Results: 48
    1

    Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations.

    Published in:
    Medical Oncology, 2015, v. 32, n. 3, p. 1, doi. 10.1007/s12032-014-0474-x
    By:
    • Tamiya, Akihiro;
    • Tamiya, Motohiro;
    • Shiroyama, Takayuki;
    • Saijo, Nobuhiko;
    • Nakatani, Takeshi;
    • Minomo, Shojiro;
    • Tsuji, Taisuke;
    • Takeuchi, Naoko;
    • Omachi, Naoki;
    • Kurata, Kanako;
    • Suzuki, Hidekazu.;
    • Okamoto, Norio;
    • Okishio, Kyoichi;
    • Hirashima, Tomonori;
    • Atagi, Shinji
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer.

    Published in:
    Medical Oncology, 2015, v. 32, n. 3, p. 1, doi. 10.1007/s12032-015-0535-9
    By:
    • Meattini, Icro;
    • Francolini, Giulio;
    • Scotti, Vieri;
    • Luca Cardillo, Carla;
    • Cappelli, Sabrina;
    • Meacci, Fiammetta;
    • Furfaro, Ilaria;
    • Muntoni, Cristina;
    • Scoccianti, Silvia;
    • Detti, Beatrice;
    • Mangoni, Monica;
    • Nori, Jacopo;
    • Orzalesi, Lorenzo;
    • Fambrini, Massimiliano;
    • Bianchi, Simonetta;
    • Livi, Lorenzo
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48